CDC warns Costa Rica travelers as chikungunya cases rise

The U.S. Centers for Disease Control and Prevention has issued a travel health notice for Costa Rica after an outbreak of chikungunya virus in one of the country’s most popular beach regions, cautioning visitors about the risk of severe illness from the mosquito-borne disease.

Level 2 notice targets Guanacaste, a major resort hub

According to the CDC’s updated destination page for Costa Rica, published in mid-July 2026, health officials have documented an outbreak of chikungunya in Guanacaste Province, a Pacific coast region known for its resort towns, surf breaks, and all-inclusive beach hotels. The notice advises travelers to the affected area to “practice enhanced precautions,” which is the agency’s Level 2 advisory tier for travel health risks.

Recent travel coverage indicates that the warning specifically highlights popular beach communities in Guanacaste, where the virus has been spreading in local mosquito populations. Costa Rica’s own health authorities declared an active outbreak earlier in July, prompting closer monitoring in tourist centers along the province’s shoreline.

While the CDC has not advised against travel to Costa Rica as a whole, the notice urges U.S. travelers heading to Guanacaste to pay particular attention to mosquito protection measures. The advisory underscores that even visitors staying at upscale coastal resorts or private villas may be exposed, since the mosquitoes that transmit chikungunya live close to human habitation and can breed in small collections of standing water.

The travel health notice places Costa Rica among a growing list of tropical destinations in the Americas grappling with mosquito-borne outbreaks. For many U.S. travelers, Guanacaste is a key gateway to beach vacations in Central America, making the development especially significant for the current summer and upcoming winter high seasons.

What chikungunya is and why “severe illness” is a concern

Chikungunya is a viral infection spread primarily by Aedes mosquitoes, the same genus that can transmit dengue and Zika. Public health references describe its hallmark symptoms as sudden high fever, intense joint pain, muscle aches, headache, and rash. The illness typically begins three to seven days after a mosquito bite from an infected insect.

Most patients recover within about a week, but joint pain and stiffness can linger for months, and in some cases for years, significantly affecting mobility and quality of life. Travel health material notes that while many infections are self-limiting, the virus can cause severe disease, particularly among older adults, people with underlying medical conditions such as heart or kidney disease, and pregnant individuals.

Reports summarizing recent outbreaks in the Americas emphasize that, although deaths from chikungunya are relatively rare, complications such as neurological problems, heart inflammation, and severe dehydration have been documented. These risks underpin the CDC’s warning that travelers may experience “severe illness,” even if the majority of cases remain mild to moderate.

Unlike malaria, there is no vaccine or specific antiviral treatment for chikungunya currently recommended for travelers. Care focuses on rest, fluids, and pain relief, with hospitalization reserved for serious or complicated cases. That lack of a preventive shot or cure makes personal protection against mosquito bites the main line of defense for visitors to Guanacaste.

How the notice affects upcoming Costa Rica trips

The Level 2 travel health notice does not prohibit travel or automatically trigger entry restrictions, but it may influence how travelers plan and insure their trips to Costa Rica. Some travel insurance policies reference CDC travel health notice levels in their fine print, which can affect coverage decisions for trip cancellation or medical care abroad.

Travel industry discussion in recent days suggests that most airlines and tour operators continue to serve Guanacaste’s airports and resorts as scheduled. However, some companies are reminding customers to review health advisories before departure and to consider purchasing policies that explicitly cover mosquito-borne illnesses and medical evacuation from remote beach areas.

For travelers who are pregnant, immunocompromised, or managing chronic conditions, publicly available guidance typically advises a more cautious approach. Health resources recommend a pre-trip consultation with a clinician or travel-medicine provider to discuss individual risk, review routine and destination-specific vaccines, and plan what to do if symptoms appear while abroad or soon after returning home.

U.S. travelers planning multi-stop itineraries across Central America are also being encouraged by travel health sources to monitor updates for neighboring countries, where similar mosquito-borne viruses may be circulating. Even if the current CDC notice focuses on Costa Rica, the ecological conditions that support Aedes mosquitoes extend across many tropical and subtropical regions.

Practical steps travelers can take to reduce risk

The CDC’s general travel health recommendations for mosquito-borne illnesses emphasize a layered approach. Travelers are urged to use insect repellent that contains ingredients such as DEET, picaridin, IR3535, or oil of lemon eucalyptus, following product instructions carefully and reapplying as directed, especially after swimming or heavy sweating in hot coastal climates.

Lightweight, long-sleeved shirts, long pants, and socks can help reduce exposed skin, particularly during early morning and late afternoon hours when Aedes mosquitoes are often most active. Many travel health guides recommend clothing treated with permethrin for additional protection, especially for visitors spending extended time outdoors or on nature excursions away from resort areas.

Accommodation choices also play a role. Rooms with effective air-conditioning, intact window and door screens, or properly hung bed nets can help limit mosquito entry. Travelers renting private homes or villas are advised to check for standing water in containers, plant pots, and outdoor areas, and to work with property managers to eliminate potential breeding sites.

Travel health resources further stress the importance of recognizing early symptoms. Anyone who develops sudden fever, severe joint pain, or a combination of fever and rash during or after a stay in Guanacaste is advised in public guidance to seek prompt medical evaluation and to inform clinicians about recent travel. Early assessment can help distinguish chikungunya from dengue and other infections that may require different management.

Monitoring the situation as the season progresses

As of late July 2026, publicly available information indicates that the chikungunya outbreak is concentrated in Costa Rica’s Guanacaste Province, with no broad restriction on travel to the rest of the country. However, both local health authorities and international agencies are continuing to track case numbers, mosquito activity, and any signs that the virus is spreading into new regions or urban centers.

Travelers with upcoming trips are encouraged by travel health specialists and consumer advocates to check the CDC’s Costa Rica destination page and official bulletins from Costa Rica’s Ministry of Health in the days leading up to departure. These resources are typically updated as outbreaks evolve, including any expansion to new areas or changes in recommended precautions.

Observers note that mosquito-borne outbreaks in tropical destinations often fluctuate with rainfall patterns, temperature, and local control efforts such as fumigation and public campaigns to remove standing water. As a result, the intensity of risk in Guanacaste may change over the course of the rainy season and into the drier high season favored by many international visitors.

For now, the travel alert serves as a signal that beachgoers heading to this popular tropical destination should factor health precautions into their packing lists and daily routines, even while enjoying the region’s surf, wildlife, and coastal scenery. The main message from current public guidance is not to abandon trips outright, but to recognize the potential for severe illness and take concrete steps to lower the chances of mosquito bites.